| Line 145: |
Line 145: |
| | **Organisms can be killed using radiation or chemicals so that they still possess the [[Adaptive Immune System - WikiBlood#Antigen Recognition|antigens]] to stimulate an immune response, but the organisms are unable to replicate inside the host | | **Organisms can be killed using radiation or chemicals so that they still possess the [[Adaptive Immune System - WikiBlood#Antigen Recognition|antigens]] to stimulate an immune response, but the organisms are unable to replicate inside the host |
| | **Toxins are inactivated to produce a toxoid which will still have the [[Adaptive Immune System - WikiBlood#Antigen Recognition|antigens]] needed to produce an immune response but will not be harmful to the host | | **Toxins are inactivated to produce a toxoid which will still have the [[Adaptive Immune System - WikiBlood#Antigen Recognition|antigens]] needed to produce an immune response but will not be harmful to the host |
| − | **Needs two doses (for an explanation on the [[Lymphocytes - WikiBlood#T cells|T cell]] response click [[B cell differentiation - WikiBlood#T-Cell Dependent and Independent Responses|here]]) | + | **Needs two doses (for an explanation on the [[Lymphocytes#T cells|T cell]] response click [[B cell differentiation - WikiBlood#T-Cell Dependent and Independent Responses|here]]) |
| | **1:4000 formaldehyde is the current preparation | | **1:4000 formaldehyde is the current preparation |
| | **Inactivants containing azuridines and beta propiolactone are being developed which do not leave a persistent infectious viral fraction (like formaldehyde) | | **Inactivants containing azuridines and beta propiolactone are being developed which do not leave a persistent infectious viral fraction (like formaldehyde) |
| Line 174: |
Line 174: |
| | *Some stimulate the immune system to amplify the adaptive immune response to [[Adaptive Immune System - WikiBlood#Antigen Recognition|antigens]] | | *Some stimulate the immune system to amplify the adaptive immune response to [[Adaptive Immune System - WikiBlood#Antigen Recognition|antigens]] |
| | **E.g. Pathogen-associated molecular patterns (PAMPs) | | **E.g. Pathogen-associated molecular patterns (PAMPs) |
| − | **E.g. PAMP-like adjuvants which assist naive [[Lymphocytes - WikiBlood#T cells|T cell]] priming | + | **E.g. PAMP-like adjuvants which assist naive [[Lymphocytes#T cells|T cell]] priming |
| | | | |
| − | *Different subtypes of [[Lymphocytes - WikiBlood#Helper CD4+|T helper cells]] are stimulated by different adjuvants | + | *Different subtypes of [[Lymphocytes#Helper CD4+|T helper cells]] are stimulated by different adjuvants |
| | **E.g. Aluminium salts generate bias [[T cell differentiation - WikiBlood#TH2 Cells|T helper II]] responses for [[Immunoglobulins - WikiBlood|'''antibody''']]-mediated immunity | | **E.g. Aluminium salts generate bias [[T cell differentiation - WikiBlood#TH2 Cells|T helper II]] responses for [[Immunoglobulins - WikiBlood|'''antibody''']]-mediated immunity |
| | **E.g. Killed mycobacteria generate IL-12 producing good '''cell'''-mediated immunity | | **E.g. Killed mycobacteria generate IL-12 producing good '''cell'''-mediated immunity |
| Line 203: |
Line 203: |
| | | | |
| | *Immunity for the extracellular phase requires neutralising [[Immunoglobulins - WikiBlood|'''antibody''']] | | *Immunity for the extracellular phase requires neutralising [[Immunoglobulins - WikiBlood|'''antibody''']] |
| − | **[[Lymphocytes - WikiBlood#B Cells|B cells]] needed | + | **[[Lymphocytes#B Cells|B cells]] needed |
| | **[[T cell differentiation - WikiBlood#TH2 Cells|T helper type II cells]] needed (for the [[MHC - WikiBlood#MHC II|MHC class II pathway]]) | | **[[T cell differentiation - WikiBlood#TH2 Cells|T helper type II cells]] needed (for the [[MHC - WikiBlood#MHC II|MHC class II pathway]]) |
| | **Live vaccine can be used | | **Live vaccine can be used |
| Line 209: |
Line 209: |
| | **Subunit vaccine can be used | | **Subunit vaccine can be used |
| | | | |
| − | *Immunity for the intracellular phase requires [[Lymphocytes - WikiBlood#Cytotoxic CD8+|'''CD8+ cytotoxic T cells''']] | + | *Immunity for the intracellular phase requires [[Lymphocytes#Cytotoxic CD8+|'''CD8+ cytotoxic T cells''']] |
| | **[[MHC - WikiBlood#MHC I|MHC class I pathway]] | | **[[MHC - WikiBlood#MHC I|MHC class I pathway]] |
| | **Only live vaccine can be used to get into cells (entering via the endogenous pathway) | | **Only live vaccine can be used to get into cells (entering via the endogenous pathway) |
| Line 216: |
Line 216: |
| | | | |
| | *Extracellular bacterial infection needs [[Immunoglobulins - WikiBlood|'''antibody''']] production for [[Complement - WikiBlood#Opsonisation|opsonisation]] and to activate the [[Complement - WikiBlood|complement pathways]] | | *Extracellular bacterial infection needs [[Immunoglobulins - WikiBlood|'''antibody''']] production for [[Complement - WikiBlood#Opsonisation|opsonisation]] and to activate the [[Complement - WikiBlood|complement pathways]] |
| − | **[[Lymphocytes - WikiBlood#B Cells|B cells]] needed | + | **[[Lymphocytes#B Cells|B cells]] needed |
| | **[[T cell differentiation - WikiBlood#TH2 Cells|T helper type II cells]] needed | | **[[T cell differentiation - WikiBlood#TH2 Cells|T helper type II cells]] needed |
| | | | |